Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,434 | 575 | 98.2% |
| Education | $122.77 | 3 | 1.3% |
| Unspecified | $50.00 | 1 | 0.5% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $1,276 | 80 | $0 (2024) |
| Novo Nordisk Inc | $1,231 | 80 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,185 | 71 | $0 (2024) |
| PFIZER INC. | $722.11 | 51 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $580.33 | 35 | $0 (2024) |
| ABBVIE INC. | $540.21 | 28 | $0 (2024) |
| Amgen Inc. | $409.73 | 27 | $0 (2024) |
| GlaxoSmithKline, LLC. | $383.01 | 25 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $381.53 | 26 | $0 (2023) |
| Merck Sharp & Dohme LLC | $365.05 | 26 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,713 | 90 | Novo Nordisk Inc ($263.70) |
| 2023 | $1,566 | 87 | Lilly USA, LLC ($214.44) |
| 2022 | $1,669 | 91 | ABBVIE INC. ($228.77) |
| 2021 | $838.17 | 51 | Lilly USA, LLC ($166.84) |
| 2020 | $477.53 | 34 | Lilly USA, LLC ($141.27) |
| 2019 | $798.22 | 55 | Lilly USA, LLC ($161.28) |
| 2018 | $1,088 | 71 | Novo Nordisk Inc ($212.10) |
| 2017 | $1,458 | 100 | Boehringer Ingelheim Pharmaceuticals, Inc. ($164.95) |
All Payment Transactions
579 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: PAIN | ||||||
| 12/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Diabetes | ||||||
| 11/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: DIABETES | ||||||
| 11/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: Diabetes | ||||||
| 11/08/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: VACCINE | ||||||
| 11/07/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: Oncology | ||||||
| 11/04/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: Endocrinology | ||||||
| 11/01/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: Cardio-renal | ||||||
| 10/28/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/23/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: Inflammation | ||||||
| 10/17/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $25.17 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: RESPIRATORY | ||||||
| 10/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: DIABETES | ||||||
| 10/02/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.26 | General |
| 10/02/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: VACCINES | ||||||
| 10/01/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: Diabetes | ||||||
| 09/27/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: Bone Health | ||||||
| 09/26/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: Respiratory | ||||||
| 09/25/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: Diabetes | ||||||
| 09/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: PAIN | ||||||
| 09/03/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: Respiratory | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| NN2211-3965 | Novo Nordisk AS | $50.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,011 | 2,910 | $293,244 | $146,866 |
| 2022 | 32 | 1,569 | 3,158 | $377,108 | $179,575 |
| 2021 | 27 | 1,190 | 1,984 | $224,516 | $102,274 |
| 2020 | 22 | 1,028 | 1,898 | $263,109 | $111,848 |
All Medicare Procedures & Services
104 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 136 | 1,143 | $91,440 | $54,770 | 59.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 117 | 360 | $77,400 | $30,373 | 39.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 56 | 128 | $37,120 | $16,333 | 44.0% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 117 | 355 | $26,270 | $12,862 | 49.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 34 | 34 | $11,350 | $9,575 | 84.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 42 | 42 | $9,450 | $5,281 | 55.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 21 | 21 | $6,426 | $2,995 | 46.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 34 | $4,930 | $2,070 | 42.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 22 | 176 | $8,800 | $1,897 | 21.6% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 25 | 25 | $3,250 | $1,787 | 55.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 83 | 83 | $2,075 | $1,469 | 70.8% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 41 | 41 | $2,665 | $1,373 | 51.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 43 | 44 | $1,540 | $1,331 | 86.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 37 | 37 | $1,850 | $1,119 | 60.5% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 51 | 51 | $1,377 | $902.70 | 65.6% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 16 | 17 | $2,010 | $617.61 | 30.7% |
| G0506 | Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | Office | 2023 | 13 | 13 | $845.00 | $541.41 | 64.1% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 22 | 22 | $1,540 | $451.44 | 29.3% |
| G0010 | Administration of hepatitis b vaccine | Office | 2023 | 12 | 13 | $390.00 | $382.20 | 98.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 25 | 27 | $945.00 | $287.88 | 30.5% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 14 | 156 | $936.00 | $192.08 | 20.5% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 38 | 65 | $520.00 | $181.50 | 34.9% |
| 81002 | Urinalysis, manual test | Office | 2023 | 18 | 23 | $115.00 | $75.02 | 65.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 160 | 610 | $131,150 | $54,055 | 41.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 129 | 677 | $54,160 | $33,537 | 61.9% |
About Dr. Michael Paul Gimness, M.D
Dr. Michael Paul Gimness, M.D is a Family Medicine healthcare provider based in Plant City, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/02/2005. The National Provider Identifier (NPI) number assigned to this provider is 1518958222.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Paul Gimness, M.D has received a total of $9,607 in payments from pharmaceutical and medical device companies, with $1,713 received in 2024. These payments were reported across 579 transactions from 53 companies. The most common payment nature is "Food and Beverage" ($9,434).
As a Medicare-enrolled provider, Gimness has provided services to 4,798 Medicare beneficiaries, totaling 9,950 services with total Medicare billing of $540,563. Data is available for 4 years (2020–2023), covering 104 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Plant City, FL
- Active Since 11/02/2005
- Last Updated 05/21/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1518958222
Products in Payments
- Ozempic (Drug) $636.55
- FARXIGA (Drug) $557.64
- TRULICITY (Drug) $458.98
- JARDIANCE (Drug) $427.38
- BREZTRI (Drug) $371.93
- XARELTO (Drug) $292.70
- Kerendia (Drug) $267.63
- BASAGLAR (Drug) $266.64
- Otezla (Drug) $219.95
- TRELEGY ELLIPTA (Drug) $217.29
- MOUNJARO (Drug) $214.11
- Victoza (Drug) $209.53
- VRAYLAR (Drug) $207.34
- PREVNAR 20 (Biological) $196.39
- JANUVIA (Drug) $191.52
- UBRELVY (Drug) $177.40
- NURTEC ODT (Drug) $171.92
- Rybelsus (Drug) $164.23
- EMGALITY (Drug) $153.17
- QULIPTA (Drug) $146.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Plant City
Dr. Nicholas Heathscott, Md, MD
Family Medicine — Payments: $14,389
Dr. Omar Aref, Md, MD
Family Medicine — Payments: $7,718
Dr. Liji George, Md, MD
Family Medicine — Payments: $7,400
Dr. Maryam Abid
Family Medicine — Payments: $4,751
Dr. Gwyneth Davis, M.d, M.D
Family Medicine — Payments: $3,779
Dr. Michael Salvato, M.d, M.D
Family Medicine — Payments: $3,115